share_log
Benzinga ·  07/19 08:36

60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Signed Clinical Trial Agreements With Three Planned Trial Sites for the Tafenoquine Babesiosis Study

60度药品股价上涨,公司与三个计划试验地签订了Tafenoquine Babesiosis研究的临床试验协议

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发